Sometimes the most consequential sentence a journalist receives is a bureaucratic one. “Following your prompt,” wrote Martina Vidláková of the Czech Republic’s National Accreditation Bureau (NAB), “NAB has reached out to Charles University to obtain further information on the issue.” Six months into this investigation, that single clause is the first evidence that anyone with institutional authority over the First Faculty of Medicine has asked it to account for itself. It is not a finding. It is not a verdict. But it is a door opening, from the outside, not the inside, and that distinction matters enormously.
The faculty’s press office did not respond to requests for comment. That silence, now several rounds of contact deep, stands in stark relief against the NAB’s movement. Vidláková was precise about the architecture of Czech quality assurance: “The primary responsibility for quality of higher education lies with the higher education institutions. NAB does not collect or systematically monitor data on student assessment in individual courses. Rather, NAB evaluates the internal quality assurance mechanisms.” In plain terms: the accreditor’s remit is systems and policies, not individual student outcomes. Charles University is, per Vidláková, due for re-evaluation next year. Whatever NAB surfaces in its outreach to the university will feed into that cycle.
This matters for the question this column has pursued without asserting an answer: whether international students, among them Indians, sitting the First Faculty’s six-year General Medicine programme at €24,250 per year face differential academic outcomes compared with domestic Czech students. The faculty publishes no enrolment total, no India-specific admission data, and no disaggregated pass-rate or progression data. That absence is not an allegation of wrongdoing. It is a documented gap in the public record, and now a gap Prague’s accreditor has been asked to examine. The question remains open. The investigation advances.
An earlier reply from the bureau, dated 29 July 2026, had added a note of procedural candour, observing that “the description of the issue is rather vague and general”, a fair challenge to any journalism that asks a regulator to investigate something it cannot yet specify. The honest answer: the vagueness is structural. When an institution publishes nothing, there is no specific datum to dispute, only a pattern of opacity to probe. The absence of data is not itself evidence of harm. But the absence of data about a self-paying international cohort, one paying fees that dwarf what domestic students pay, is, at minimum, a governance question that an accreditation review is well-placed to pursue.
The System That Exports the Problem
On 15 August 2024, Prime Minister Narendra Modi told the nation from the Red Fort that even after a decade in which, as he put it, the country had ensured the availability of roughly 100,000 medical seats, “around 25,000 youth go abroad for medical education.” The arithmetic of departure is simple. University World News documents the price asymmetry bluntly: a government MBBS costs approximately ₹3,00,000 for the full course; a private college can charge up to ₹1.2 crore. India’s 780 medical colleges held 1,18,137 MBBS seats in 2024-25, up from 387 colleges and 51,348 seats in 2013-14, a 102 per cent rise in colleges over eleven years, per the Ministry of Health and Family Welfare’s submissions to Parliament. The expansion is real. So is the pressure: Careers360 and NTA data show NEET-UG registrations climbing from 11,38,890 in 2017 to 24,06,079 in 2024, candidates seeking places across MBBS, BDS and AYUSH streams. The competition for government MBBS seats, at a price a middle-class family can absorb without a decade of debt, remains ferocious. Prague, Moscow, Bishkek and Tbilisi are where the arithmetic leads the family that cannot win that lottery but will not pay ₹1.2 crore.
What happens when those students return? The Foreign Medical Graduate Examination is the filter. In the June 2025 session, 6,707 candidates passed of 36,039 who appeared, an 18.61 per cent pass rate. The June 2026 session, the most recent on record, recorded 4,635 passing of 36,300 who appeared, 12.77 per cent. Across the 2013-to-2024 period documented by Careers360 and NBEMS, the rate has ranged from 4.93 per cent to 24.54 per cent. These are per-session figures; candidates may sit again. But a system in which, in any given sitting, roughly seven or eight of every ten foreign-trained graduates fail the licensing screen is a system with a serious quality-alignment problem, at home, abroad, or both.
A Resignation and What It Signals
On 25 July 2026, Union Education Minister Dharmendra Pradhan tendered his resignation over the NEET examination controversy and the exam-integrity protests that had spread across the country. As of 25 July 2026, the date of the report, the Prime Minister had not formally accepted it. Pradhan’s offer to step down did not arise from anything connected to Prague or to the foreign-enrolment question; to suggest otherwise would be false. But the two phenomena are symptoms of the same institutional stress. A national entrance examination that saw registrations more than double in seven years, that has been touched by paper-leak allegations and that now has a minister’s career resting on its credibility, that examination is also the reason 25,000 students a year board flights to Europe and Central Asia rather than enter an Indian lecture theatre. The integrity of NEET and the opacity of foreign medical programmes are not separate stories. They are the upstream and the downstream of a single broken pipeline.
What Accountability Looks Like from Here
The NAB’s scheduled re-evaluation of Charles University next year is now, thanks to its own outreach, no longer a routine cycle. Vidláková confirmed that the bureau had not previously received any complaint or submission on this matter. It has now engaged. Whether the First Faculty of Medicine gives the accreditor answers it has declined to give journalists, and whether those answers address the specific question of international-student progression and assessment, will be the test of whether Czech quality-assurance mechanisms are substantive or procedural.
For the 25,000 Indians who leave each year, and for the larger number who sit the FMGE and do not pass a given session, the test is more immediate. They are the people in the gap between India’s insufficient affordable seats and the foreign institutions whose internal data the public cannot read. The gap is not a metaphor. It is a live policy failure with a human cost that neither Delhi nor Prague has yet been willing to quantify openly.
That is the story. It remains unresolved. It continues.
If you have studied or taught at the First Faculty of Medicine or another international medical programme and are willing to speak on record or background, write to the Opinion desk.
